"Pfizer Settles Lipitor Antitrust Lawsuit for $93 Million"

Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors, who accused the company of conspiring with Ranbaxy Laboratories to delay sales of generic versions of the cholesterol drug Lipitor. The settlement, which still requires a judge's approval, comes after more than a decade of litigation. Pfizer did not admit liability and called the allegations "factually and legally without merit." The distributors' case will continue against Ranbaxy, and lawyers for the plaintiffs said the settlement provides "immediate economic relief" to class members and avoids the risk of continued litigation.